SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting concerns about enterprise reliability and pressure on the shares. Traders are split between viewing the disruption as a serious hit to customer trust and treating it as a temporary setback and buying opportunity; cyberattack claims remain speculation, with Microsoft reporting no evidence of malicious activity.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras quarterly results and stronger revenue outlook, alongside discussion of a Microsoft cloud agreement, drove attention as traders focused on its AI-inference growth prospects. The bullish reaction over earnings and potential short covering was tempered by concerns about GAAP losses, valuation, and whether the post-results jump would hold.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos quarterly earnings beat and raised outlook, including stronger AI infrastructure expectations, are driving attention, but shares have struggled to hold gains. Traders are weighing the AI networking opportunity against declining gross margins and slower product-order growth, with some questioning whether growth has peaked while others see a longer-term networking cycle.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA submission has been pushed to mid-2027 amid ongoing FDA discussions about assay refinement, prompting a sharp selloff. Traders disagree on whether this is a manageable manufacturing and regulatory hurdle that leaves the clinical data intact or a sign of execution problems; concerns about management credibility and possible dilution are also prominent.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials better-than-expected quarterly results and upbeat outlook are drawing attention, but shares have barely responded and have slipped. Traders are debating whether strong news was already priced in and options volatility is weighing on the reaction, while others point to Nvidia-related tech weakness; views on the companys longer-term chip-equipment demand remain more positive.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

The EMAs confirmation of a negative CHMP opinion on MIPLYFFA (arimoclomol) for Niemann-Pick disease type C in Europe is driving attention and weighing on shares. Traders debate the lost European opportunity and managements next steps, while some argue the U.S. business, cash position and possible acquisition interest remain supportive; buyout expectations are speculation.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff below a key round-number level and weakening technical support dominate discussion, with traders split between buying an oversold dip and expecting further declines. Some link the pressure to broader risk-off conditions and leveraged liquidations, though the conversation does not establish a single confirmed cause.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

Reports that Samsung is discussing a potential acquisition of Modine have driven attention, with traders treating the talks as unconfirmed and debating whether a deal will materialize and offer an adequate premium. Some view the move as a rumor-driven spike and warn it could fade if negotiations fall through.

Cardinal Infrastructure Group, Inc. provides infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. It delivers wet utility installations of water, sewer, and stormwater systems, as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services. The company was founded on June 12, 2025 and is headquartered in Raleigh, NC.

Cardinal Infrastructure Group Inc - Ordinary Shares - Class A

A sharp selloff followed Cardinals Q3 margin deterioration and project cost revisions, withdrawal of full-year guidance, and CFO resignation. Traders debate whether the damage is a temporary execution problem and an overreactionciting cash, backlog, and the share-repurchase authorizationor evidence of deeper management and business risks.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment includes To-Home businesses, which include Ele.me, local services and delivery platforms, and Taoxianda, and To-Destination segment businesses, which include Amap, the provider of mobile digital maps, navigation and real-time traffic information, and restaurant and local services guide platforms. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solutions. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is drawing attention as Nvidia-related controversy and concerns about tighter U.S. chip controls fuel selling and speculation about whether the companys AI business could lose access to Nvidia hardware. Traders debate whether that risk outweighs Alibabas development of its own chips, with earnings approaching as another focus.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$INO $MRNA $PGEN $SLS @SellasgpsCurativeBAT11 This is what the FDA finally saw and why they approved $INO . $PGEN is not a better vaccine, the FDA approved $INO because they demonstrated that they are better. That’s what the battle for “Accelerated Approval,” was after $PGEN got the product first to market. 

$PGEN Was able to get those stats for year 1 and two only because they required debulking and scoping.

If they didn’t do that, their stats would have been trash.

mitchrich

BioSwings™

Jane Oriol

Tony M

P Reddy

TopOptionsAlerts®

John Matin

Keith

Stephen

$INO $MRNA $PGEN $SLS Part 3. As a Biostatistician I was heavily vested in $PGEN  last year and sold some time after approval as documented on both boards. 
Unfortunately $INO will make PAPZIMEOS obsolete in the coming months. 
PAPZIMEOS requires surgical removal of visible papillomas before its third and fourth doses during the 12-week treatment period, whereas VOCERYQ doesn&#39;t require surgery during its nine-week dosing period. 
PAPZIMEOS&#39; 12-month assessment starts after the 12 week dosing period, while VOCERYQ&#39;s is measured from Day O. No Doctor/Surgeon with a good conscience will advise their patients to go with a much inferior PAPZIMEOS. No reason to get upset at me for saying this but that’s the way technology works. $INO VOCERYQ will capture majority of $PGEN market in the coming months. 
Plus $INO has a very deep platform with near term Catalysts. First and foremost, VGX-3100 in China has completed Phase 3 with excellent results another Billion dollar opportunity. ✌️🙏❤️‍🩹

StockTwits for iOS

Inovio Pharmaceuticals Inc

Moderna Inc

Precigen Inc

SELLAS Life Sciences Group Inc

 This is what the FDA finally saw and why they approved 

 is not a better vaccine, the FDA approved 

 because they demonstrated that they are better. That’s what the battle for “Accelerated Approval,” was after 

 Was able to get those stats for year 1 and two only because they required debulking and scoping.

If they didn’t do that, their stats would have been trash.